查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610246

藥用甘油市場：按應用、來源分類 - 2025-2030 年全球預測

Pharmaceutical Glycerine Market by Utility (Care Products, Excipient), Source (Animal, Plant) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥用甘油市場價值為3747萬美元，預計2024年將達3940萬美元，複合年成長率為5.94%，預計2030年將達5613萬美元。

藥用甘油是一種多功能多元醇化合物，由於其無毒、吸濕和溶劑特性，在各種應用中發揮至關重要的作用。它主要用於藥品、化妝品和個人保健產品中作為保濕劑、防腐劑和甜味劑。它的需求源自於其增強產品穩定性、質地和保存期限的能力。最終用途包括從藥物（作為活性成分的載體）到消費品（用於乳霜、乳液和膠囊）。市場成長受到消費者對健康和保健產品意識不斷提高以及製藥和化妝品行業需求不斷成長的影響。生物技術應用的擴展，特別是藥物傳遞系統的應用，意味著新商機的到來。這些趨勢使公司能夠探索甘油配方的創新，以提高生物有效性和功能。在永續性的推動下，對生物基甘油的研究不斷成長，代表了綠色化學和環保產品潛在應用的另一個有前景的途徑。然而，市場成長受到原料價格波動以及有關產品安全和功效的嚴格監管要求等因素的限制。供應鏈中斷是另一個挑戰。公司可以透過投資多元化採購並遵守國際標準以確保產品一致性來緩解這些限制。在創新方面，甘油衍生物的增強、生物技術和精製製程的新應用等領域提供了差異化和競爭優勢的機會。與研究機構合作可以促進這些領域的突破。儘管市場呈現穩定成長的特點，但競爭日益加劇，需要不斷創新來維持市場地位。為了有效挖掘市場潛力，企業需要加強研發力度，並對不斷變化的消費者偏好和監管環境做出快速反應。

主要市場統計
基準年[2023] 3747萬美元
預計年份 [2024] 3940萬美元
預測年份 [2030] 5613萬美元
複合年成長率（%） 5.94%

市場動態：揭示快速發展的藥用甘油市場的關鍵市場洞察

供需的動態交互作用正在改變藥用甘油市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加在藥物製劑中作為賦形劑的使用
    • 增加天然成分的使用
    • 增加在眼壓疾病治療的應用
  • 市場限制因素
    • 藥用甘油的副作用
  • 市場機會
    • 活性化藥用甘油的研發活動
    • 改善供應鏈和分銷網路
  • 市場挑戰
    • 低成本替代品的可用性

波特五力：駕馭藥用甘油市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥用甘油市場的外部影響

外部宏觀環境因素在塑造藥用甘油市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥用甘油市場的競爭狀況

藥用甘油市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣醫藥甘油市場供應商的績效評估

FPNV 定位矩陣是評估藥用甘油市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與推薦藥物繪製甘油市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對藥用甘油市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加在藥物中作為賦形劑的使用
      • 增加天然成分的使用
      • 在眼壓疾病治療的應用不斷增加
    • 抑制因素
      • 藥用甘油的負面影響
    • 機會
      • 增加研發活動以開發藥用甘油
      • 改善供應鏈和分銷網路
    • 任務
      • 低成本替代品的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥用甘油市場公共事業

  • 護理產品
  • 賦形劑

第7章藥用甘油市場：依來源分類

  • 動物
  • 植物

第8章北美和南美藥用甘油市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太藥用甘油市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲藥用甘油市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Archer Daniels Midland Company
  • Emery Oleochemicals Group
  • Fisher Scientific Co. LLC
  • GJ Chemical
  • Godrej Group
  • Merck KGaA
  • Munzer Bioindustrie GmbH
  • Oleon NV
  • Pon Pure Chemicals Group
  • Procter and Gamble Company
  • Reagents
  • Renewable Energy Group Inc.
  • Sulzer Ltd
  • The Chemical Company
  • Viterra Magdeburg GmbH
Product Code: MRR-742BD5183818

The Pharmaceutical Glycerine Market was valued at USD 37.47 million in 2023, expected to reach USD 39.40 million in 2024, and is projected to grow at a CAGR of 5.94%, to USD 56.13 million by 2030.

Pharmaceutical glycerine, a versatile polyol compound, plays a pivotal role in various applications due to its non-toxic, hygroscopic, and solvent properties. It is primarily used in drug formulations, cosmetics, and personal care products as a humectant, preservative, and sweetener. Its necessity stems from its ability to enhance the stability, texture, and shelf life of products. The end-use scope spans pharmaceuticals, where it acts as a carrier for active ingredients, to consumer goods where it is employed in creams, lotions, and capsules. Market growth is influenced by increasing demand from the pharmaceutical and cosmetics sectors, alongside rising consumer awareness concerning health and wellness products. The expansion in biotechnological applications, particularly in drug delivery systems, signifies an emerging opportunity. Embracing these trends, companies can explore innovations in glycerine formulations to improve bioavailability and functionality. Growing research into bio-based glycerine, driven by sustainability trends, represents another promising avenue, with potential applications in green chemistry and eco-friendly products. However, market growth is constrained by factors such as fluctuating raw material prices and stringent regulatory requirements regarding product safety and efficacy. Supply chain disruptions pose additional challenges. Companies can mitigate these limitations by investing in diversified sourcing and complying with international standards to ensure product consistency. Regarding innovation, areas such as enhanced glycerine derivatives, novel applications in biotechnology, and bio-refinery processes present opportunities for differentiation and competitive advantage. Collaborations with research institutions could facilitate breakthroughs in these areas. The market exhibits traits of steady growth, with increasing competition and a need for continuous innovation to maintain market position. Companies are urged to bolster research and development efforts and adapt swiftly to evolving consumer preferences and regulatory landscapes to harness market potential effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 37.47 million
Estimated Year [2024] USD 39.40 million
Forecast Year [2030] USD 56.13 million
CAGR (%) 5.94%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing usage as excipients in pharmaceutical preparations
    • Rising adoption of natural ingredients
    • Increasing application in the treatment of eye pressure conditions
  • Market Restraints
    • Adverse effects of pharmaceutical glycerine
  • Market Opportunities
    • Rising R&D activities to develop pharmaceutical glycerine
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Availability of low cost substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Glycerine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Glycerine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Glycerine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Glycerine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Glycerine Market

A detailed market share analysis in the Pharmaceutical Glycerine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Glycerine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Glycerine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Glycerine Market

A strategic analysis of the Pharmaceutical Glycerine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Glycerine Market, highlighting leading vendors and their innovative profiles. These include Archer Daniels Midland Company, Emery Oleochemicals Group, Fisher Scientific Co. L.L.C., GJ Chemical, Godrej Group, Merck KGaA, Munzer Bioindustrie GmbH, Oleon NV, Pon Pure Chemicals Group, Procter and Gamble Company, Reagents, Renewable Energy Group Inc., Sulzer Ltd, The Chemical Company, and Viterra Magdeburg GmbH.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Glycerine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Utility, market is studied across Care Products and Excipient.
  • Based on Source, market is studied across Animal and Plant.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing usage as excipients in pharmaceutical preparations
      • 5.1.1.2. Rising adoption of natural ingredients
      • 5.1.1.3. Increasing application in the treatment of eye pressure conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of pharmaceutical glycerine
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities to develop pharmaceutical glycerine
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of low cost substitutes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Glycerine Market, by Utility

  • 6.1. Introduction
  • 6.2. Care Products
  • 6.3. Excipient

7. Pharmaceutical Glycerine Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Plant

8. Americas Pharmaceutical Glycerine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Glycerine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Glycerine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Archer Daniels Midland Company
  • 2. Emery Oleochemicals Group
  • 3. Fisher Scientific Co. L.L.C.
  • 4. GJ Chemical
  • 5. Godrej Group
  • 6. Merck KGaA
  • 7. Munzer Bioindustrie GmbH
  • 8. Oleon NV
  • 9. Pon Pure Chemicals Group
  • 10. Procter and Gamble Company
  • 11. Reagents
  • 12. Renewable Energy Group Inc.
  • 13. Sulzer Ltd
  • 14. The Chemical Company
  • 15. Viterra Magdeburg GmbH

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GLYCERINE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GLYCERINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY EXCIPIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023